Alpha Emitter Radium-223 and Survival in Metastatic Prostate CancerChris Parker, Oliver Sartor, Sten Nilsson et al.|New England Journal of Medicine|2013Cited by 3.3k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studiesRichard Pötter, Ina M. Jürgenliemk‐Schulz, Kari Tanderup et al.|Clinical and Translational Radiation Oncology|2018Cited by 932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort studyAlina Sturdza, Jacob Christian Lindegaard, Richard Pötter et al.|Radiotherapy and Oncology|2016Cited by 695
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort studyRichard Pötter, Janaki Hadjiev, Kari Tanderup et al.|The Lancet Oncology|2021Cited by 624
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trialOliver Sartor, Christopher Parker, Anders Widmark et al.|The Lancet Oncology|2014Cited by 491